Clinical Trials Directory

Trials / Completed

CompletedNCT02776553

A Physical Activity Program in End-state Liver Disease

A Physical Activity Program in End-stage Liver Disease: Pilot Study Assessing Changes in Physical Fitness, Sarcopenia, and the Metabolic Profile

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study is to improve both physical fitness and sarcopenia of patients with ESLD who are potentially eligible for liver transplantation through a 12-week physical training program. Secondary aims will focus on changes in anthropometrics, body composition, quality of life, and metabolic profile. This is a randomized clinical trial including 50 patients, with half allocated to the active group (physical training program) and half to standard of care.

Conditions

Interventions

TypeNameDescription
OTHERNutritional consultationDietary advice will be provided at the beginning of the study and individually tailored to the participant's usual eating habits plus amino acid supplement including 10 grams of branched-chain amino acids
BEHAVIORALPhysical training programPhysical activity prescription will target ≥10,000 steps/day, taking into account all activities performed throughout the day, although the increment in activity should be no less than 3000 steps/day above the baseline.
BEHAVIORALBehavioral modification therapyThe behavior modification theory will be applied in the form of a structured set of cues and questions between investigator and participant at each visit in order to provide individually tailored counseling to enhance internal motivation and facilitate behavior change toward physical activity and dietary improvement that are adaptable to each participant's usual habits.

Timeline

Start date
2016-06-01
Primary completion
2020-05-01
Completion
2020-06-01
First posted
2016-05-18
Last updated
2020-08-06
Results posted
2020-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02776553. Inclusion in this directory is not an endorsement.